Drontal
Commercial- Indications
- Animal parasites
Company intelligence / Profile preview
Vetoquinol has a broad commercial portfolio of veterinary medicines and non-medicinal products targeting pain/inflammation, dermatology, hygiene/care, udder health, reproduction, cardio-nephrology, behavior management. Recent regulatory milestones include FDA approvals for Clevor (emetic agent) and UpCard CA1 (for canine pulmonary edema). The company continues to launch new products such as VetPowerment.[5]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vetoquinol.